Overview

Migraine Treatment in ED

Status:
Withdrawn
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Randomized pilot feasibility study evaluating the impact of introducing behavioral treatment for migraine in the Emergency Department (ED) and prescribing migraine preventive medications in the ED. The study will examine the effect of these treatments, both individually and in combination, on pain severity and headache-related disability. This study is designed to examine the feasibility of comparing four interventions for ED patients presenting with migraine. Group 1: Starting topiramate; Group 2: Doing a brief behavioral intervention; Group 3: Treating with combination therapy of topiramate and behavioral intervention; and Group 4: Standard of Care.
Phase:
N/A
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Naproxen
Sumatriptan
Topiramate